Potential role of p53 on metallothionein induction in human epithelial breast cancer cells

被引:0
|
作者
L Z Fan
M G Cherian
机构
[1] University of Western Ontario,Department of Pathology
来源
British Journal of Cancer | 2002年 / 87卷
关键词
metallothionein; p53; apoptosis; breast cancer;
D O I
暂无
中图分类号
学科分类号
摘要
The expression and induction of metallothionein has been associated with protection against oxidative stress and apoptosis. This study examines the effect of tumour suppressor protein p53 on metallothionein expression following CdCl2 treatment in eight human epithelial breast cancer cell lines differing in p53 and oestrogen-receptor status. Cells were treated with 10 μM CdCl2 for 24 h and metallothionein protein levels were measured by cadmium binding assay. MCF7 cells which are p53-positive (p53+) and oestrogen-receptor-positive showed a large induction in metallothionein synthesis by 10.79±1.36-fold. Other breast cancer cell lines which are p53-negative (p53−) and oestrogen-receptor-negative or weakly oestrogen-receptor-positive showed a small induction ranging from 1.40±0.10 to 3.65±0.30-fold. RT–PCR analysis showed an induction of metallothionein mRNA in MCF7 cells by about 1.61±0.08-fold, while in HCC1806 cells (p53−, oestrogen-receptor-negative) by 1.11±0.13-fold, and in MDA-MB-231 (p53−, oestrogen-receptor-negative) by 1.25±0.06-fold. Metallothionein localisation was determined by immunohistochemical staining. Prior to metal treatment, metallothionein was localised mainly in the cytoplasm of MCF7 and MDA-MB-231 cells. After treatment with 10 μM CdCl2 for 24 h, MCF7 cells showed intense nuclear and cytoplasmic staining for metallothionein, while MDA-MB-231 cells showed staining in the cytoplasm with weak nuclear staining. Apoptosis induced by 10–40 μM CdCl2 at time points between 4 and 48 h was examined with TUNEL assay. In MCF7 cells, apoptosis increased with higher concentrations of CdCl2, it peaked at 6–8 h and appeared again at 48 h for all concentrations of CdCl2 tested. In MDA-MB-231 cells, apoptosis remained at low levels for 10–40 μM CdCl2 at all time points. Studies on cadmium uptake showed similar uptake and accumulation of cadmium at 8 and 24 h in all the cell lines. The data demonstrate that treatment of epithelial breast cancer cells with 10 μM CdCl2 for 24 h caused a greater induction of metallothionein protein and mRNA expression in p53+ and oestrogen-receptor-positive cells as compared to p53− and oestrogen-receptor-negative or weakly oestrogen-receptor-positive cells. This effect may be associated with the occurrence of apoptosis and suggests a role for p53 and oestrogen-receptor on the expression and induction of metallothionein in epithelial cells.
引用
收藏
页码:1019 / 1026
页数:7
相关论文
共 50 条
  • [31] Normal breast epithelial cells induce p53-dependent apoptosis and p53-independent cell cycle arrest of breast cancer cells
    Robert-Alain Toillon
    Valérie Chopin
    Nathalie Jouy
    William Fauquette
    Bénoni Boilly
    Xuefen Le Bourhis
    Breast Cancer Research and Treatment, 2002, 71 : 269 - 280
  • [32] Zeranol Down-Regulates p53 Expression in Primary Cultured Human Breast Cancer Epithelial Cells through Epigenetic Modification
    Ye, Weiping
    Xu, Pingping
    Jen, Robert
    Feng, Eric
    Zhong, Saiyi
    Li, Hong
    Lin, Shu-Hong
    Liu, Jie-Yu
    Lin, Young C.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2011, 12 (03) : 1519 - 1532
  • [33] Possible role of p53/Mieap-regulated mitochondrial quality control as a tumor suppressor in human breast cancer
    Gaowa, Siqin
    Futamura, Manabu
    Tsuneki, Masayuki
    Kamino, Hiroki
    Tajima, Jesse Y.
    Mori, Ryutaro
    Arakawa, Hirofumi
    Yoshida, Kazuhiro
    CANCER SCIENCE, 2018, 109 (12) : 3910 - 3920
  • [34] Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding site
    Do, TN
    Rosal, RV
    Drew, L
    Raffo, AJ
    Michl, J
    Pincus, MR
    Friedman, FK
    Petrylak, DP
    Cassai, N
    Szmulewicz, J
    Sidhu, G
    Fine, RL
    Brandt-Rauf, PW
    ONCOGENE, 2003, 22 (10) : 1431 - 1444
  • [35] Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding site
    Tamara N Do
    Ramon V Rosal
    Lisa Drew
    Anthony J Raffo
    Josef Michl
    Matthew R Pincus
    Fred K Friedman
    Daniel P Petrylak
    Nicholas Cassai
    Joseph Szmulewicz
    Gurdip Sidhu
    Robert L Fine
    Paul W Brandt-Rauf
    Oncogene, 2003, 22 : 1431 - 1444
  • [36] Regulatory role of p53 in cancer metabolism via SCO2 and TIGAR in human breast cancer
    Won, Kyu Yeoun
    Lim, Sung-Jig
    Kim, Gou Young
    Kim, Youn Wha
    Han, Sang-Ah
    Song, Jeong Yoon
    Lee, Dong-Ki
    HUMAN PATHOLOGY, 2012, 43 (02) : 221 - 228
  • [37] The p53 miRNA interactome and its potential role in the cancer clinic
    Krell, Jonathan
    Frampton, Adam E.
    Colombo, Teresa
    Gall, Tamara M. H.
    De Giorgio, Alex
    Harding, Victoria
    Stebbing, Justin
    Castellano, Leandro
    EPIGENOMICS, 2013, 5 (04) : 417 - 428
  • [38] Effect of berberine on p53 expression by TPA in breast cancer cells
    Kim, Sangmin
    Han, Jeonghun
    Kim, Nam-Young
    Lee, Se Kyung
    Cho, Dong Hui
    Choi, Min-Young
    Kim, Jee Soo
    Kim, Jung-Han
    Choe, Jun-Ho
    Nam, Seok Jin
    Lee, Jeong Eon
    ONCOLOGY REPORTS, 2012, 27 (01) : 210 - 215
  • [39] P53 mediated regulation of metalolothionen transcription in breast cancer cells
    Ostrakhovitch, Elena A.
    Olsson, Per-Erik
    von Hofsten, Jonas
    Cherian, M. George
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 102 (06) : 1571 - 1583
  • [40] Depletion of CTCF in Breast Cancer Cells Selectively Induces Cancer Cell Death via p53
    Lee, Ji-Yeon
    Mustafa, Muhammad
    Kim, Clara Yuri
    Kim, Myoung Hee
    JOURNAL OF CANCER, 2017, 8 (11): : 2124 - 2131